Tradewinds Capital Management’s ResMed RMD Stock Holding History

Tradewinds Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-43	Closed	-$11K	–	793
2021 Q2	$11K	Hold	43	–	–	﹤0.01%	467
2021 Q1	$8K	Hold	43	–	–	﹤0.01%	490
2020 Q4	$9K	Hold	43	–	–	﹤0.01%	443
2020 Q3	$7K	Hold	43	–	–	﹤0.01%	447
2020 Q2	$8K	Hold	43	–	–	﹤0.01%	428
2020 Q1	$6K	Hold	43	–	–	﹤0.01%	429
2019 Q4	$7K	Hold	43	–	–	﹤0.01%	459
2019 Q3	$6K	Hold	43	–	–	﹤0.01%	437
2019 Q2	$5K	Hold	43	–	–	﹤0.01%	458
2019 Q1	$4K	Hold	43	–	–	﹤0.01%	483
2018 Q4	$5K	Hold	43	–	–	﹤0.01%	471
2018 Q3	$5K	Buy	+43	New	+$4.71K	﹤0.01%	499
2017 Q2	–	Sell	-43	Closed	-$3K	–	699
2017 Q1	$3K	Hold	43	–	–	﹤0.01%	551
2016 Q4	$3K	Hold	43	–	–	﹤0.01%	508
2016 Q3	$3K	Hold	43	–	–	﹤0.01%	502
2016 Q2	$3K	Hold	43	–	–	﹤0.01%	515
2016 Q1	$2K	Hold	43	–	–	﹤0.01%	563
2015 Q4	$2K	Buy	+43	New	+$2.42K	﹤0.01%	552

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tradewinds Capital Management's RMD Position: Q3 2021 in Review

Tradewinds Capital Management sold out of ResMed (RMD) in Q3 2021, closing a stake of 43 shares — an estimated $11K sold.

Tradewinds Capital Management first reported a position in RMD in Q4 2015 and held it in 18 quarters. The position peaked at $11K in Q2 2021. 686 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

Tradewinds Capital Management reported no remaining ResMed position as of Q3 2021 after selling out during the quarter.
Tradewinds Capital Management sold 43 ResMed shares in Q3 2021, an estimated $11K.
Tradewinds Capital Management first reported a position in ResMed in Q4 2015 and held it in 18 quarters.
Tradewinds Capital Management's ResMed position peaked at $11K in Q2 2021.
686 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on Tradewinds Capital Management's 13F filing for Q3 2021, filed 4 Nov 2021.